HHS – Page 3 – medicarereport.org

Monday, May 20, 2024

Latest:

Eileen Cook August 11, 2023August 11, 2023 0 Comments CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D, Medicare Star Ratings

Medicare Advantage in 2023: Premiums, Out-of-Pocket Limits, Cost Sharing, Supplemental Benefits, Prior Authorization, and Star Ratings

(By Nancy Ochieng, Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for the Kaiser Family Foundation Published: Aug

CMS Health Care Finance Health Care Redesign HHS Legislative Update Medicare - General Part D/Prescription Drugs

Eileen Cook August 9, 2023August 9, 2023 0 Comments CMS, Healthcare Costs, Healthcare Finance, HHS, Inflation Reduction Act of 2022, Medicare Part D

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

(By Juliette Cubanski for the Kaiser Family Foundation published August 8, 2023) The Inflation Reduction Act of 2022 (the Act),

Alzheimer's/Dementia Caregiver CMS HHS Medicare - General

Eileen Cook August 2, 2023August 2, 2023 0 Comments Alzheimer's Disease, CMS, Dementia, GUIDE, medicare, Older Adults

Guiding an Improved Dementia Experience

The Centers for Medicare & Medicaid Services (CMS) announced its new dementia care model. The model, Guiding an Improved Dementia

CMS HHS Legislative Update Medicare Advantage

Eileen Cook July 27, 2023July 27, 2023 0 Comments CMS, congress, HHS, Medicare Advantage, Medicare Advantage Prior Authorization

Medicare Advantage prior authorization reform bill passes House committee

(By Andrew Cass for Becker’s Hospital Review) A bill aiming to reform the Medicare Advantage prior authorization process was included

CMS Health Care Finance Health Insurance HHS Medical Debt Part D/Prescription Drugs

Eileen Cook July 11, 2023July 11, 2023 0 Comments Junk Health Plans, Medical debt, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Surprise health care bills

HHS Announces Actions to Protect Consumers and Lower Health Care Costs

(Source – www.cms.gov/newsroom) The U.S. Department of Health and Human Services (HHS), announced actions to protect consumers from junk health

CMS Health Care Redesign HHS Medicare Advantage

Eileen Cook June 22, 2023June 22, 2023 0 Comments CMS, HHS, Medicare Advantage, Prior Authorization

Lawmakers want CMS’ prior authorization proposal to go further

(By Andrew Cass for Becker’s Hospital Review) More than 230 U.S. representatives and 61 senators are asking HHS and CMS

CMS Health Care Finance Health Care Redesign HHS Medicare - General Part D/Prescription Drugs

Eileen Cook June 12, 2023June 12, 2023 0 Comments Average Sales Price (ASP), CMS, HHS, Medicare Part B, The Inflation Reduction Act, The Medicare Prescription Drug Inflation Rebate Program

Inflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation

(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of

Affordable Care Act (ACA)Artificial Intelligence Health Care - General Health Insurance HHS

Eileen Cook May 26, 2023May 26, 2023 0 Comments "Denial Nurse", ACA, AI, Claims Denials and Appeals, Health Insurance companies

Denials of Health Insurance Claims Are Rising — And Getting Weirder

(By Elisabeth Rosenthal for KFF Health News) Millions of Americans in the past few years have run into this experience:

HHS Medicare - General Telehealth

Eileen Cook May 11, 2023May 11, 2023 0 Comments COVID-19, HHS, medicare, Telehealth

Medicare telehealth flexibilities to remain in place until 2024

(By Naomi Diaz for Becker’s Hospital Review) The COVID-19 public health emergency is set to expire on May 11, but

Health Care Finance HHS Medicare - General Part D/Prescription Drugs

Eileen Cook April 11, 2023April 11, 2023 0 Comments HHS, Inflation Reduction Act of 2022, Medicare Part B, Medicare Part B drugs, Rebates

HHS cuts 7 drugs from Medicare Part B rebates list

(By Rylee Wilson for Becker’s Hospital Review) HHS has removed seven drugs from its initial list of 27 drugs subject